Papers
2
Total Citations
15
H-Index
2
About
Carl Hofmann is a pioneering researcher at the intersection of laboratory automation and vaccine development, whose work has significantly advanced high-throughput screening methodologies. His primary research areas encompass robotic liquid handling systems, automated biochemical assays, and live-attenuated vaccine analytics, with a particular focus on accelerating drug discovery and vaccine development pipelines. Hofmann’s major contributions include the development of an open-sourced, inexpensive robotic liquid handler that democratizes access to automation in biochemical assays, a breakthrough that has garnered 11 citations since 2024. This innovation directly addresses the critical need for efficient testing in pharmaceutical companies, particularly within High Throughput Analytics groups. Additionally, his fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccine development, cited 4 times, represents a vital tool in combating the global dengue fever threat that affects half the world’s population. By enabling precise, scalable analysis of vaccine candidates, Hofmann’s work supports the development of essential live virus vaccines. His achievements bridge the gap between cost-effective automation and critical public health challenges, making him a notable figure in modern analytical research and development.
Research Focus
Key Achievements
Top Papers
- 1
- 2